Do presenting symptoms predict treatment decisions and survival in glioblastoma? Real-world data from 1458 patients in the Swedish brain tumor registry.

Helena BruhnBjörn TavelinLena RosenlundRoger Henriksson

Published in: Neuro-oncology practice (2024)

This extensive real-life study reveals that initial cognitive impairment acts as an independent negative predictive factor for treatment decisions and adversely affects survival outcomes in glioblastoma patients.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
cognitive impairment
prognostic factors
patient reported outcomes
deep learning
case report
artificial intelligence